Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical.
TRNS - Transcat, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$123.60
DETAILS
HIGH:
$160.00
LOW:
$94.00
MEDIAN:
$113.00
CONSENSUS:
$123.60
UPSIDE:
42.91%
Stock News
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September.
Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS
Dimensional Fund Advisors LP grew its position in Transcat, Inc. (NASDAQ: TRNS) by 3.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,033 shares of the scientific and technical instruments company's stock after purchasing an additional 9,266 shares during the
Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
Transcat Q1 Earnings Call Highlights
Transcat NASDAQ: TRNS reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said demand remained strong across its regulated end markets, including life sciences, aerospace and defense, and energy.
Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates
Transcat, Inc. (TRNS) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.59 per share a year ago.
Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal First Quarter 2027 Results with Double-Digit Service Organic Revenue Growth and Service Gross Margin Expansion.
Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time.
Transcat: Mission Critical Company With A Strong Moat
Transcat, Inc. is rated BUY, leveraging recurring revenue from government-mandated calibration services and a strong competitive moat. TRNS's growth is driven by high-margin services, strategic M&A, and recent expansion into Latin America, targeting life sciences and regulated industries. Despite a 58% YTD share price gain, TRNS trades at 18x forward EV/EBITDA, well below its historical peak valuation multiples.
Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer.
2 Instruments Stocks Likely to Beat Short-Term Industry Challenges
The increasing adoption of industrial automation, focus on higher energy efficiency and optimum resource utilization should drive the Zacks Instruments ??? Control industry.
Transcat Inc (TRNS) Shares Surge 6.9% -- What GF Score of 93 Tells Investors
On May 29, 2026, Transcat Inc (TRNS) shares rose 6.9% to a current price of $84.70. This recent uptick follows a strong performance over the past week and month
Transcat, Inc. (TRNS) Q4 2026 Earnings Call Transcript
Transcat, Inc. (TRNS) Q4 2026 Earnings Call Transcript
Compared to Estimates, Transcat (TRNS) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Transcat (TRNS) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Transcat, Inc. (TRNS) Q4 Earnings Surpass Estimates
Transcat, Inc. (TRNS) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.64 per share a year ago.
Transcat Q4 Earnings Call Highlights
Transcat NASDAQ: TRNS reported double-digit revenue growth in both of its business segments for the fiscal fourth quarter, as newly appointed President and CEO Jaime Irick told investors the company plans to continue emphasizing organic service growth, margin expansion, acquisitions and rentals.
Transcat Reports Strong Fiscal Fourth Quarter 2026 Financial Results with Continued High Single-Digit Service Organic Revenue* Growth
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal Fourth Quarter 2026 Financial Results with Continued High Single-Digit Service Organic Revenue* Growth.
Gear Up for Transcat (TRNS) Q4 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Transcat (TRNS) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 p.m. Eastern Time
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 p.m. Eastern Time.
Sensata (ST) Q1 Earnings and Revenues Surpass Estimates
Sensata (ST) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.78 per share a year ago.
Price Targets
Transcat upgraded to Outperform from Market Perform at Northland
$95.00
(was $76.99)
Ted Jackson
·
Northland Securities
Transcat price target lowered to $113 from $138 at Craig-Hallum
$113.00
(was $98.84)
Greg Palm
·
Craig-Hallum
Transcat price target lowered to $110 from $130 at Northland
$110.00
(was $98.84)
Ted Jackson
·
Northland Securities
H.C. Wainwright Reiterates Buy Rating on Transcat Inc. (TRNS)
$156.00
(was $104.18)
Scott Buck
·
H.C. Wainwright
Transcat price target lowered to $138 from $150 at Craig-Hallum
$138.00
(was $116.91)
Greg Palm
·
Craig-Hallum
Transcat Inc. (TRNS) PT Raised to $160 at Oppenheimer
$160.00
(was $141.86)
Martin Yang
·
Oppenheimer
Transcat Inc. (TRNS) PT Raised to $125 at Oppenheimer
$125.00
(was $104.71)
Martin Yang
·
Oppenheimer
Roth Capital Maintains Buy on Transcat, Raises Price Target to $94
$94.00
(was $84.87)
Roth Capital
Northland Capital Markets Maintains Outperform on Transcat, Raises Price Target to $100
$100.00
(was $85.69)
Northland Securities
Craig-Hallum Maintains Buy on Transcat, Raises Price Target to $92
$92.00
(was $85.65)
Craig-Hallum
HC Wainwright & Co. Maintains Buy on Transcat, Raises Price Target to $96
$96.00
(was $83.52)
H.C. Wainwright